Gustave Roussy Institut, a major French cancer research center, has entered a strategic partnership with French startup
Embleema, which runs a blockchain network for healthcare. The aim is to apply blockchain technology to health data sharing applications for oncology clinical research.
The strategic partnership uses Embleema’s technology to integrate and store health data on a digital exchange. This will enable patients of the Gustave Roussy Institut to have full control over their own data.
The data exchange will be a crucial step in accelerating drug development, as pharmaceutical companies and researchers now have easy access to regulatory-grade data to evaluate the safety and effectiveness of experimental drugs. More importantly, healthcare data will finally become reusable for biological sciences research, taking a shot at breaking the data silo which typically hinders the research and development of new drugs.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
